SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-16-004950
Filing Date
2016-04-14
Accepted
2016-04-14 16:05:59
Documents
36
Period of Report
2016-02-29

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q s102973_10q.htm 10-Q 149816
2 EXHIBIT 31.1 s102973_ex31-1.htm EX-31.1 8511
3 EXHIBIT 31.2 s102973_ex31-2.htm EX-31.2 8497
4 EXHIBIT 32.1 s102973_ex32-1.htm EX-32.1 4765
  Complete submission text file 0001615774-16-004950.txt   1464242

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cnlm-20160229.xsd EX-101.SCH 25416
6 XBRL CALCULATION FILE cnlm-20160229_cal.xml EX-101.CAL 24754
7 XBRL DEFINITION FILE cnlm-20160229_def.xml EX-101.DEF 76056
8 XBRL LABEL FILE cnlm-20160229_lab.xml EX-101.LAB 170249
9 XBRL PRESENTATION FILE cnlm-20160229_pre.xml EX-101.PRE 125040
10 XBRL INSTANCE FILE cnlm-20160229.xml EX-101.INS 146865
Mailing Address 24 NEW ENGLAND EXECUTIVE PARK SUITE 105 BURLINGTON MA 01803
Business Address 24 NEW ENGLAND EXECUTIVE PARK SUITE 105 BURLINGTON MA 01803 781-652-4500
CB Pharma Acquisition Corp. (Filer) CIK: 0001619551 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 001-36757 | Film No.: 161571800
SIC: 6770 Blank Checks